Amneal Pharmaceuticals Inc (NYSE:AMRX)

5.63
Delayed Data
As of May 14
 -0.01 / -0.18%
Today’s Change
3.45
Today|||52-Week Range
7.45
+23.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues860.5M824.4M775.8M1.7B
 
 
 
 
 
Cost of Goods Sold439.4M371.5M407.7M809.2M
 
 
 
 
 
Depreciation And Amortization68.6M88.3M106.7M137.4M
 
 
 
 
 
 
Operating ExpensesGross Income352.4M364.6M261.4M716.4M
 
 
 
 
 
General Expenses265.0M319.5M281.4M424.6M
 
 
 
 
 
Research And Development77.0M80.5M77.4M194.2M
 
 
 
 
 
Total Operating Expenses773.0M779.3M795.9M1.4B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income87.4M45.1M-20.1M291.8M
 
 
 
 
 
Extraordinary Credit--0.0031.0M6.0M
 
 
 
Extraordinary Charge-47.8M-580.6M-418.9M-337.2M
 
 
 
 
 
Interest Expense On Debt27.3M41.4M54.4M143.6M
 
 
 
 
 
Other Expenses45.9M-464.0K10.4M-19.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income59.4M-576.3M-451.0M-202.7M
 
 
 
 
 
Income Taxes-20.4M-104.3M-18.3M-1.4M
 
 
 
 
 
Minority Interest0.000.000.00-31.6M
 
 
Net Income39.0M-472.0M-469.3M-20.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS69.6M71.1M71.9M127.3M
 
 
 
 
 
Shares To Calculate EPS Diluted72.0M71.1M71.9M127.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.54-$6.63-$6.53-$0.16
 
 
 
 
 
EPS Diluted$0.54-$6.63-$6.53-$0.16